Fractionation of mouse bone-marrow cells limits functional efficacy in non-reperfused mouse model of acute myocardial infarction

Annals of Medicine

Volumn 44, Issue 8, 2012, Pages 829-835

  Koskenvuo, Juha W ^a,b,c   Sievers, Richard E ^a   Zhang, Yan ^a   Angeli, Franca S ^a   Lee, Brian ^a   Shih, Henry ^a   Ye, Jianqin ^a   Boyle, Andrew J ^a   Yeghiazarians, Yerem ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

Author keywords

Cardiac regeneration; Cell therapy; Extract; Mononuclear cell; Mouse; Myocardial infarction; Progenitor cell; Unfractionated

Indexed keywords

FICOLL;

ACUTE HEART INFARCTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTICLE; BODY WEIGHT; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; CELL FRACTIONATION; CELL POPULATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; EXPERIMENTAL MODEL; HEART INFARCTION SIZE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE CAPILLARY; HEART WEIGHT; HEMATOPOIETIC STEM CELL; HISTOLOGY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANALYSIS OF VARIANCE; ANIMALS; BONE MARROW TRANSPLANTATION; CELL FRACTIONATION; ECHOCARDIOGRAPHY; MALE; MICE; MICE, INBRED C57BL; MYOCARDIAL INFARCTION; MYOCARDIUM; ORGAN SIZE; STROKE VOLUME; VENTRICULAR REMODELING;

EID: 84870856658     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2012.672026     Document Type: Article

References (41)

1. L osordo DW, Dimmeler S. Th erapeutic angiogenesis and vasculogenesis for ischemic disease: part II: cell-based therapies. Circulation. 2004;109:2692-7.
2. R osenzweig A. Cardiac cell therapy-m ixed results from mixed cells. N Engl J Med. 2006;355:1274-7.
3. W ollert KC, Drexler H. Clinical applications of stem cells for the heart. Circ Res. 2005;96:151-63.
4. A ssmus B, Schachinger V, Teupe C, Britten M, Lehmann R, Dobert N, et al. Transplantation of Progenitor Cells and Regeneration Enhancement in Acute Myocardial Infarction (TOPCARE-AMI). Circulation. 2002;106:3009-17.
5. W ollert KC, Meyer GP, Lotz J, Ringes-Lichtenberg S, Lippolt P, Breidenbach C, et al. Intracoronary autologous bone-marrow cell transfer aft er myocardial infarction: the BOOST randomised controlled clinical trial. Lancet. 2004;364:141-8.
6. F ernandez-Aviles F, San Roman JA, Garcia-Frade J, Fernandez ME, Penarrubia MJ, de la Fuente L, et al. Experimental and clinical regenerative capability of human bone marrow cells aft er myocardial infarction. Circ Res. 2004;95:742-8.
7. S chachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N Engl J Med. 2006;355:1210-21.
8. H ashemi SM, Ghods S, Kolodgie FD, Parcham-Azad K, Keane M, Hamamdzic D, et al. A placebo controlled, dose-ranging, safety study of allogenic mesenchymal stem cells injected by endomyocardial delivery aft er an acute myocardial infarction. Eur Heart J. 2008;29:251-9.
9. de Silva R, Raval AN, Hadi M, Gildea KM, Bonifacino AC, Yu ZX, et al. Intracoronary infusion of autologous mononuclear cells from bone marrow or granulocyte colony-stimulating factor-mobilized apheresis product may not improve remodelling, contractile function, perfusion, or infarct size in a swine model of large myocardial infarction. Eur Heart J. 2008;29:1772-82.
10. Herbots L, D' h ooge J, Eroglu E, Th ijs D, Ganame J, Claus P, et al. Improved regional function aft er autologous bone marrow-derived stem cell transfer in patients with acute myocardial infarction: a randomized, double-blind strain rate imaging study. Eur Heart J. 2009;30: 662-70.
11. Uemura R, Xu M, Ahmad N, Ashraf M. Bone marrow stem cells prevent left ventricular remodeling of ischemic heart through paracrine signaling. Circ Res. 2006;98:1414-21.
12. G necchi M, He H, Noiseux N, Liang OD, Zhang L, Morello F, et al. Evidence supporting paracrine hypothesis for Akt-modified mesenchymal stem cell-mediated cardiac protection and functional improvement. FASEB J. 2006;20:661-9.
13. Yeghiazarians Y, Zhang Y, Prasad M, Shih H, Saini SA, Takagawa J, et al. Injection of bone marrow cell extract into infarcted hearts results in functional improvement comparable to intact cell therapy. Mol Th er. 2009;17:1250-6.
14. A ssmus B, Tonn T, Seeger FH, Yoon CH, Leistner D, Klotsche J, et al. Red blood cell contamination of the final cell product impairs the efficacy of autologous bone marrow mononuclear cell therapy. J Am Coll Cardiol. 2010;55:1385-94.
15. D eindl E, Zaruba MM, Brunner S, Huber B, Mehl U, Assmann G, et al. G-CSF administration aft er myocardial infarction in mice attenuates late ischemic cardiomyopathy by enhanced arteriogenesis. FASEB J. 2006;20:956-8.
16. Y eghiazarians Y, Khan M, Angeli FS, Zhang Y, Jahn S, Prasad M, et al. Cytokine combination therapy with long-acting erythropoietin and granulocyte colony stimulating factor improves cardiac function but is not superior than monotherapy in a mouse model of acute myocardial infarction. J Card Fail. 2010;16:669-78.
17. v an der Bogt KE, Sheikh AY, Schrepfer S, Hoyt G, Cao F, Ransohoff KJ, et al. Comparison of diff erent adult stem cell types for treatment of myocardial ischemia. Circulation. 2008;118:S121-9.
18. S pringer ML, Sievers RE, Viswanathan MN, Yee MS, Foster E, Grossman W, et al. Closed-chest cell injections into mouse myocardium guided by high-resolution echocardiography. Am J Physiol Heart Circ Physiol. 2005;289:H1307-14.
19. T akagawa J, Zhang Y, Wong ML, Sievers RE, Kapasi NK, Wang Y, et al. Myocardial infarct size measurement in the mouse chronic infarction model: comparison of area-and length-based approaches. J Appl Physiol. 2007;102:2104-11.
20. Z hang Y, Takagawa J, Sievers RE, Khan MF, Viswanathan MN, Springer ML, et al. Validation of the wall motion score and myocardial performance indexes as novel techniques to assess cardiac function in mice aft er myocardial infarction. Am J Physiol Heart Circ Physiol. 2007;292:H1187-92.
21. S chachinger V, Erbs S, Elsasser A, Haberbosch W, Hambrecht R, Holschermann H, et al. Improved clinical outcome aft er intracoronary administration of bone-marrow-derived progenitor cells in acute myocardial infarction: final 1-year results of the REPAIR-AMI trial. Eur Heart J. 2006;27:2775-83.
22. Z hang Y, Sievers RE, Prasad M, Mirsky R, Shih H, Wong ML, et al. Timing of bone marrow cell therapy is more important than repeated injections aft er myocardial infarction. Cardiovasc Pathol. 2011;20:204-12.
23. van Laake LW, Passier R, Doevendans PA, Mummery CL. Human embryonic stem cell-derived cardiomyocytes and cardiac repair in rodents. Circ Res. 2008;102:1008-10.
24. Caspi O, Huber I, Kehat I, Habib M, Arbel G, Gepstein A, et al. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J Am Coll Cardiol. 2007;50:1884-93.
25. S un J, Li SH, Liu SM, Wu J, Weisel RD, Zhuo YF, et al. Improvement in cardiac function aft er bone marrow cell therapy is associated with an increase in myocardial inflammation. Am J Physiol Heart Circ Physiol. 2009;296:H43-50.
26. K olpakov MA, Seqqat R, Rafiq K, Xi H, Margulies KB, Libonati JR, et al. Pleiotropic eff ects of neutrophils on myocyte apoptosis and left ventricular remodeling during early volume overload. J Mol Cell Cardiol. 2009;47:634-45.
27. S wijnenburg RJ, Govaert JA, van der Bogt KE, Pearl JI, Huang M, Stein W, et al. Timing of bone marrow cell delivery has minimal eff ects on cell viability and cardiac recovery aft er myocardial infarction. Circ Cardiovasc Imaging. 2010;3:77-85.
28. L iu F, Smith J, Zhang Z, Cole R, Herron BJ. Genetic heterogeneity of skin microvasculature. Dev Biol. 2010;340:480-9.
29. C lark LD, Clark RK, Heber-Katz E. A new murine model for mammalian wound repair and regeneration. Clin Immunol Immunopathol. 1998;88:35-45.
30. S eeger FH, Tonn T, Krzossok N, Zeiher AM, Dimmeler S. Cell isolation procedures matter: a comparison of diff erent isolation protocols of bone marrow mononuclear cells used for cell therapy in patients with acute myocardial infarction. Eur Heart J. 2007;28:766-72.
31. L unde K, Solheim S, Aakhus S, Arnesen H, Abdelnoor M, Egeland T, et al. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N Engl J Med. 2006;355:1199-209.
32. H eeschen C, Lehmann R, Honold J, Assmus B, Aicher A, Walter DH, et al. Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease. Circulation. 2004;109:1615-22.
33. H eiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol. 2005;45:1441-8.
34. H ill JM, Bartunek J. The end of granulocyte colony-stimulating factor in acute myocardial infarction? Reaping the benefits beyond cytokine mobilization. Circulation. 2006;113:1926-8.
35. Norol F, Bonnet N, Peinnequin A, Chretien F, Legrand R, Isnard R, et al. GFP-transduced CD34 and Lin-CD34-hematopoietic stem cells did not adopt a cardiac phenotype in a nonhuman primate model of myocardial infarct. Exp Hematol. 2007;35:653-61.
36. A bdel-Latif A, Bolli R, Tleyjeh IM, Montori VM, Perin EC, Hornung CA, et al. Adult bone marrow-derived cells for cardiac repair: a systematic review and meta-analysis. Arch Intern Med. 2007;167:989-97.
37. Reff elmann T, Kloner RA. Cellular cardiomyoplasty-cardiomyocytes, skeletal myoblasts, or stem cells for regenerating myocardium and treatment of heart failure? Cardiovasc Res. 2003;58:358-68.
38. H ofmann M, Wollert KC, Meyer GP, Menke A, Arseniev L, Hertenstein B, et al. Monitoring of bone marrow cell homing into the infarcted human myocardium. Circulation. 2005;111:2198-202.
39. S heikh AY, Lin SA, Cao F, Cao Y, van der Bogt KE, Chu P, et al. Molecular imaging of bone marrow mononuclear cell homing and engraft ment in ischemic myocardium. Stem Cells. 2007;25:2677-84.
40. C ao F, Wagner RA, Wilson KD, Xie X, Fu JD, Drukker M, et al. Transcriptional and functional profiling of human embryonic stem cellderived cardiomyocytes. PLoS ONE. 2008;3:e3474.
41. L i Z, Lee A, Huang M, Chun H, Chung J, Chu P, et al. Imaging survival and function of transplanted cardiac resident stem cells. J Am Coll Cardiol. 2009;53:1229-40.